Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: protocol for a phase II, single-centre, double-blind, randomised, placebo-controlled trial (the PINBOT study)
Introduction Diabetic neuropathic pain (DNP) is a debilitating complication affecting 15–20% of people with diabetes and is a predictor of depression, poor sleep and decreased quality of life. Current pharmacological treatments are often insufficient and have significant side-effects. Subcutaneous o...
Main Authors: | Bo Biering-Sörensen, Rigmor Højland Jensen, Marc Klee, Trine Hørmann Thomsen, Thomas Peter Enggaard, Martin Sabro Bitsch, Louise Simonsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/1/e074372.full |
Similar Items
-
The HortONS study. Treatment of chronic cluster headache with transcutaneous electrical nerve stimulation and occipital nerve stimulation: study protocol for a prospective, investigator-initiated, double-blinded, randomized, placebo-controlled trial
by: Ida Stisen Fogh-Andersen, et al.
Published: (2023-10-01) -
Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study
by: Mandar Jog, et al.
Published: (2020-12-01) -
Comparison of two types of extension tubes for people with Parkinson’s disease in advanced treatment with levodopa–entacapone–carbidopa intestinal gel infusions: a prospective, crossover quality study
by: Bo Biering-Sörensen, et al.
Published: (2024-01-01) -
Unveiling the mechanisms of neuropathic pain suppression: perineural resiniferatoxin targets Trpv1 and beyond
by: Safa Shehab, et al.
Published: (2023-11-01) -
Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2023-07-01)